The former co-chairs of the Scientific Panel on Higher Cortical Functions Masud Husain & Lüder Deecke explain the work and aims of the panel.
Join us now and take advantage of bonus months. Active individual members enjoy October discount for renewals and associate members special a benefit!
Latest Posts
-
-
Being an EAN Research Fellow gave me the privilege to work in Prof. Tara Spires-Jones’ Lab in The University of Edinburgh, who is a pioneer in the field of synaptic degeneration in neurodegenerative conditions and healthy aging. I worked in the lab for more than a year, carrying out the research project entitled ‘Investigating degeneration of inhibitory circuits in Alzheimer’s disease brain’. It has been an exceptional scientific and personal experience that will have a profound influence on my future career. -
Find out which sessions not to miss at EAN 2020 in Paris -
EAN signed a Memorandum of Understanding withISNA – International Society for Neuro-Immunology joining forces to promote optimal cooperation in Europe between both societies. -
EAN signed a Memorandum of Understanding with EPA – European Psychiatric Association joining forces to promote optimal cooperation in Europe between both societies. -
The BioMed Alliance started 2020 well, with a new President, President-Elect and a new Board Member. We look forward to working with them on the many interesting activities that we are planning this year. -
The global momentum to deliver a more coordinated response to the threat posed by neurological disorders is increasing. -
The BioMed Alliance leadership met with Commissioner Mariya Gabriel to discuss how to improve biomedical research in Europe on 5 February.
-
On 18 February, at a European Parliament lunch debate hosted by Christophe Hansen MEP (Luxembourg), Alzheimer Europe launched a new report presenting the findings of its collaborative analysis of recent prevalence studies and setting out updated prevalence rates for dementia in Europe. -
Dr. Tom Jenkins, Chair of the EAN e-Communication Committee interviews Prof. Didier Leys, Editor in Chief of the European Journal of Neurology -
Executive PageEAN NewsFeatured SliderExecutive Page: EAN President meets Italian Society of Neurology (SIN)
As a society aiming to promote excellence in neurology across Europe, one of the European Academy of Neurology’s greatest assets is undoubtedly the strong support from its National Neurological Society Members. As a region with a wide variety of languages, cultures, jurisdictions and needs, Europe certainly presents some challenges when it comes to coordinated action, but what we all have in common as neurologists is a strong desire to reach for excellence, ensure the best possible patient care and to work together to achieve it. -
Paper of the MonthEAN NewsFeatured SliderPaper of the Month: Apomorphine sublingual film for off episodes in Parkinson’s disease: a randomised, double-blind, placebo-controlled phase 3 study
For March 2020, we have selected: Olanow et al, Apomorphine sublingual film for off episodes in Parkinson’s disease: a randomised, double-blind, placebo-controlled phase 3 study. Lancet Neurology; 19: 135-44. -
Ireland – Hibernia (“land of winter” according to the Romans) – sits as the last outpost of North-Western Europe before the vast Atlantic Ocean that separates us from North America. Anyone who has visited the Cliffs of Moher (Figure) on the West Coast of Ireland will appreciate the precipitous point at which Europe ends. -
29 February 2020, a rare day, will be the thirteenth international Rare Disease Day. Many activities are organized in more than 100 countries to raise awareness amongst the general public and decision-makers about Rare Diseases and their impact on patients’… Continue Reading
-
Breaking newsResearchTop Articles
New EAN Guideline on the diagnosis of coma and other disorders of consciousness
The level of consciousness in patients with severe brain injury can be difficult to assess. The problem is that clinical evaluation often is unreliable – consciousness may wax and wane, requiring sufficient arousal which is often not achieved; and even when it is, patients may still be awake and aware but unable to show it due to motor paralysis or language deficits. This is true for the acute setting in intensive care and with chronic brain injury, e.g. in neurorehabilitation or nursing homes. The question is: How many unresponsive patients with acute brain injury have preserved consciousness or may have the potential for it? The answer is important for prognosis, treatment and resource allocation.